These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 17879946
1. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. J Cell Biochem; 2007 Dec 01; 102(5):1117-29. PubMed ID: 17879946 [Abstract] [Full Text] [Related]
5. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Greenaway J, Moorehead R, Shaw P, Petrik J. Gynecol Oncol; 2008 Feb 01; 108(2):385-94. PubMed ID: 18036641 [Abstract] [Full Text] [Related]
6. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Cancer Res; 2005 Apr 15; 65(8):3025-9. PubMed ID: 15833827 [Abstract] [Full Text] [Related]
7. The biology of ovarian cancer of epithelial origin. Rabinerson D, Kaplan B, Levavi H, Neri A. Isr J Med Sci; 1996 Nov 15; 32(11):1128-33. PubMed ID: 8960089 [Abstract] [Full Text] [Related]
9. Beyond tumorigenesis: cancer stem cells in metastasis. Li F, Tiede B, Massagué J, Kang Y. Cell Res; 2007 Jan 15; 17(1):3-14. PubMed ID: 17179981 [Abstract] [Full Text] [Related]
12. MicroRNAs in ovarian cancer biology and therapy resistance. van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA. Int J Biochem Cell Biol; 2010 Aug 15; 42(8):1282-90. PubMed ID: 20083225 [Abstract] [Full Text] [Related]
13. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass. Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML. Gynecol Oncol; 2009 Mar 15; 112(3):490-5. PubMed ID: 19101713 [Abstract] [Full Text] [Related]
14. The biology of ovarian cancer. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. Semin Oncol; 1998 Jun 15; 25(3):281-304. PubMed ID: 9633841 [Abstract] [Full Text] [Related]
15. Mesenchymal to epithelial transition in development and disease. Chaffer CL, Thompson EW, Williams ED. Cells Tissues Organs; 2007 Jun 15; 185(1-3):7-19. PubMed ID: 17587803 [Abstract] [Full Text] [Related]
16. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Karam AK, Chiang JW, Fung E, Nossov V, Karlan BY. Gynecol Oncol; 2009 Aug 15; 114(2):246-52. PubMed ID: 19500821 [Abstract] [Full Text] [Related]
17. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Clark-Knowles KV, Garson K, Jonkers J, Vanderhyden BC. Exp Cell Res; 2007 Jan 01; 313(1):133-45. PubMed ID: 17070800 [Abstract] [Full Text] [Related]
19. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY. Cancer Res; 2003 Jul 01; 63(13):3459-63. PubMed ID: 12839925 [Abstract] [Full Text] [Related]
20. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients. Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y. Gynecol Oncol; 2009 Aug 01; 114(2):265-72. PubMed ID: 19450871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]